ICICI Direct Issues Buy Recommendation for PPL Pharma

ICICI Direct Issues Buy Recommendation for PPL Pharma

ICICI Direct has set a target price of Rs 280 for PPL Pharma, up from the current price of Rs 226.31, indicating a potential upside of 23.72%.

More From Author

Motilal Oswal Sets NEUTRAL Rating for Nocil with Target Price of Rs 305

Motilal Oswal Sets NEUTRAL Rating for Nocil with Target Price of Rs 305

Axis Direct Issues Buy Recommendation for Gravita

Axis Direct Issues Buy Recommendation for Gravita

Leave a Reply

Your email address will not be published. Required fields are marked *